Intellectual Property Portfolio
Motac has a portfolio of world-wide patents and patent applications based around the treatment of movement disorders.
- Novel dopamine D3 receptor agonists for the treatment of Parkinson’s disease (composition-of-matter patent).
- μ (mu) opioid receptor antagonists for the treatment of dyskinesias (use patent).
- 5-HT1a receptor agonists for extending “on-time” and alleviating motor fluctuations in the treatment of Parkinson’s disease (use patent).
We are actively seeking collaborators, partners or licensees to advance these into clinical development. For further information, please contact us.